Internal Medicine, Pulmonary Disease · Hudson, NY
NPI
1144277005
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
71 Prospect Ave, Suite 210
Hudson, NY, 12534
Phone (518) 828-2566
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
1,156 services
Medicare patients, 2024
354
Average age 74
Drug cost, 2024
$1.2M
3,558 prescriptions
Company payments, 2025
$3,020
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marie Cheryle P Lingat was code 99213 (office e&m - established), 326 times for 207 patients. In total Marie Cheryle P Lingat billed 1,156 services in 32 codes, and Medicare paid $64K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 326 | 207 | $50.32 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 170 | 131 | $13.63 | $2,317 |
| 99214 Office E&M - Established | Facility | 120 | 92 | $76.00 | $9,120 |
| 99233 Hospital E&M - Subsequent | Facility | 101 | 44 | $98.32 | $9,931 |
| 94060 Pulmonary Function Testing | Facility | 61 | 61 | $8.22 | $501 |
| 94729 Pulmonary Function Testing | Facility | 58 | 58 | $7.12 | $413 |
| 94727 Pulmonary Function Testing | Facility | 58 | 58 | $9.56 | $555 |
| 99232 Hospital E&M - Subsequent | Facility | 51 | 25 | $65.14 | $3,322 |
| 99291 Critical Care E&M | Facility | 48 | 19 | $176.32 | $8,463 |
| 99204 Office E&M - New | Facility | 27 | 27 | $103.98 | $2,808 |
| 99223 Hospital E&M - Initial | Facility | 24 | 23 | $143.30 | $3,439 |
| 99406 Behavioral Health Services | Facility | 14 | 12 | $12.23 | $171 |
| 99442 Telephone Services | Office | 13 | 13 | $76.56 | $995 |
By year: 2022 $78K for 1,114 services; 2023 $77K for 1,074 services; 2024 $64K for 1,156 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marie Cheryle P Lingat prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 500 prescriptions and refills. In total Marie Cheryle P Lingat wrote 3,558 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 500 | 560 | 159 | $16K |
| Incruse Ellipta Umeclidinium Bromide | 326 | 391 | 61 | $131K |
| Breo Ellipta Fluticasone/Vilanterol | 280 | 324 | 46 | $123K |
| Prednisone Generic | 276 | 309 | 119 | $1,047 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 266 | 370 | 70 | $230K |
| Fluticasone Propionate Generic | 184 | 298 | 64 | $3,486 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 151 | 160 | 33 | $97K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 145 | 159 | 25 | $70K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 143 | 190 | 32 | $20K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 122 | 150 | 38 | $28K |
| Symbicort Budesonide/Formoterol Fumarate | 115 | 160 | 31 | $36K |
| Spiriva Respimat Tiotropium Bromide | 109 | 137 | 26 | $70K |
| Montelukast Sodium Generic | 89 | 151 | 19 | $474 |
| Azithromycin Generic | 76 | 80 | 46 | $531 |
| Spiriva Handihaler Tiotropium Bromide | 56 | 94 | 14 | $41K |
Brand drugs: 2,184 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marie Cheryle P Lingat $3,020 ($3,020 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $905.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 38 | $905 |
| GlaxoSmithKline, LLC. GSK | 39 | $574 |
| Verona Pharma, Inc. VRNA | 9 | $182 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $162 |
| Viatris Specialty LLC | 6 | $133 |
| Genzyme Corporation SNY | 5 | $115 |
| Philips North America LLC PHG | 4 | $114 |
| Grifols USA, LLC | 4 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $103 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.